Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2018 Sep 10;19(1):e51–e61. doi: 10.1016/j.clml.2018.09.002

Figure 3. Salvage IMRT administered to a patient with 5 point scale (5PS) of 5 after 6 cycles of R-CHOP.

Figure 3.

Baseline pre-therapy axial (a) and coronal images (b) in a 66 year old patient with stage III DLBCL and a 13.7 cm mesenteric mass denoted with arrows. After 6 cycles of R-CHOP, a 6.3 cm residual mass persisted with nodular foci of uptake (SUV of 13.2 and 12.4), including one focus of activity that was new since the interim pet-ct scan (c, d). The patient was treated with IMRT to a final dose of 42 Gy (e, f). Restaging PET-CT three months following completion of RT revealed complete resolution of the FDG avid foci in a decreased mesenteric mass of 5.5 cm (marked with arrows) (g, h).